RJA
OVV icon

Raymond James & Associates’s Ovintiv OVV Stock Holding History

Raymond James & Associates’s Portfolio OVV Stock Details OVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.53M Buy
196,518
+2,275
+1% +$98.4K ﹤0.01% 1390
2024
Q2 		$9.1M Sell
194,243
-10,147
-5% -$511K 0.01% 1218
2024
Q1 		$10.6M Buy
204,390
+17,639
+9% +$803K 0.01% 1118
2023
Q4 		$8.2M Buy
186,751
+3,766
+2% +$172K 0.01% 1227
2023
Q3 		$8.7M Buy
182,985
+3,840
+2% +$174K 0.01% 1118
2023
Q2 		$6.82M Buy
179,145
+16,136
+10% +$583K 0.01% 1286
2023
Q1 		$5.88M Sell
163,009
-37,396
-19% -$1.65M 0.01% 1355
2022
Q4 		$10.2M Buy
200,405
+71,189
+55% +$3.72M 0.01% 988
2022
Q3 		$5.94M Sell
129,216
-15,971
-11% -$763K 0.01% 1251
2022
Q2 		$6.42M Buy
145,187
+87,729
+153% +$4.52M 0.01% 1238
2022
Q1 		$3.11M Buy
57,458
+14,978
+35% +$645K ﹤0.01% 1833
2021
Q4 		$1.43M Sell
42,480
-10,552
-20% -$377K ﹤0.01% 2396
2021
Q3 		$1.74M Buy
53,032
+14,441
+37% +$399K ﹤0.01% 2200
2021
Q2 		$1.21M Sell
38,591
-20,042
-34% -$538K ﹤0.01% 2459
2021
Q1 		$1.4M Buy
58,633
+27,823
+90% +$595K ﹤0.01% 2274
2020
Q4 		$442K Sell
30,810
-9,307
-23% -$109K ﹤0.01% 2895
2020
Q3 		$327K Buy
40,117
+8,377
+26% +$86.4K ﹤0.01% 2897
2020
Q2 		$303K Buy
31,740
+4,429
+16% +$30.9K ﹤0.01% 2917
2020
Q1 		$74K Sell
27,311
-59,174
-68% -$777K ﹤0.01% 3265
2019
Q4 		$2.02M Sell
86,485
-42,634
-33% -$913K ﹤0.01% 1821
2019
Q3 		$2.96M Sell
129,119
-17,558
-12% -$402K ﹤0.01% 1564
2019
Q2 		$3.75M Buy
146,677
+27,810
+23% +$867K 0.01% 1391
2019
Q1 		$4.31M Buy
118,867
+46,748
+65% +$1.6M 0.01% 1267
2018
Q4 		$2.08M Sell
72,119
-1,511
-2% -$65.1K ﹤0.01% 1635
2018
Q3 		$4.83M Sell
73,630
-18,551
-20% -$1.2M 0.01% 1232
2018
Q2 		$6.01M Buy
92,181
+37,797
+70% +$2.37M 0.01% 1084
2018
Q1 		$2.99M Buy
54,384
+5,664
+12% +$336K 0.01% 1446
2017
Q4 		$3.25M Buy
48,720
+12,977
+36% +$766K 0.01% 1386
2017
Q3 		$2.1M Buy
35,743
+15,675
+78% +$766K ﹤0.01% 1611
2017
Q2 		$883K Buy
20,068
+2,442
+14% +$127K ﹤0.01% 2103
2017
Q1 		$1.03M Buy
17,626
+5,449
+45% +$327K ﹤0.01% 1963
2016
Q4 		$715K Buy
12,177
+1,491
+14% +$84.9K ﹤0.01% 2119
2016
Q3 		$559K Sell
10,686
-1,037
-9% -$46.5K ﹤0.01% 2200
2016
Q2 		$457K Buy
11,723
+2,870
+32% +$105K ﹤0.01% 2155
2016
Q1 		$270K Sell
8,853
-41,470
-82% -$955K ﹤0.01% 2404
2015
Q4 		$1.28M Buy
50,323
+8,323
+20% +$304K ﹤0.01% 1500
2015
Q3 		$1.35M Buy
42,000
+252
+0.6% +$9.65K 0.01% 1438
2015
Q2 		$2.3M Buy
41,748
+18,141
+77% +$1.15M 0.01% 1239
2015
Q1 		$1.32M Buy
23,607
+1,782
+8% +$112K 0.01% 1487
2014
Q4 		$1.51M Buy
21,825
+9,921
+83% +$844K 0.01% 1318
2014
Q3 		$1.28M Sell
11,904
-311
-3% -$34.3K 0.01% 1346
2014
Q2 		$1.45M Sell
12,215
-5,707
-32% -$661K 0.01% 1273
2014
Q1 		$1.92M Sell
17,922
-2,199
-11% -$208K 0.01% 1055
2013
Q4 		$1.82M Buy
20,121
+3,124
+18% +$285K 0.01% 1016
2013
Q3 		$1.47M Sell
16,997
-2,729
-14% -$238K 0.01% 1033
2013
Q2 		$1.67M Buy
+19,726
New +$1.83M 0.02% 904

Other funds holding OVV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's OVV Position: Q3 2024 in Review

Raymond James & Associates increased its Ovintiv (OVV) stake by 1.2% in Q3 2024, buying an estimated $98.4K and bringing the position to 196,518 shares worth $7.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Raymond James & Associates first reported a position in OVV in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.6M in Q1 2024. 549 funds tracked by Wall St. Rank hold OVV as of Q3 2024.

  • Raymond James & Associates held 196,518 shares of Ovintiv worth $7.53M as of Q3 2024.
  • Raymond James & Associates bought 2,275 Ovintiv shares in Q3 2024, an estimated $98.4K.
  • Ovintiv made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1390 holding.
  • Raymond James & Associates first reported a position in Ovintiv in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Ovintiv position peaked at $10.6M in Q1 2024.
  • 549 funds tracked by Wall St. Rank held Ovintiv as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.